NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
DBV Technologies S.A. (NASDAQ: DBVT)
Class Period: February 14, 2018 - December 19, 2018
Lead Plaintiff Deadline: March 18, 2019
Join the action: https://www.zlk.com/pslra-1/dbv-technologies-s-a-loss-form?wire=3
About the lawsuit: Throughout the class period, DBV Technologies S.A. allegedly made materially false and/or misleading
statements and/or failed to disclose that: (1) DBV Technologies' Biologics License Application ("BLA") for Viaskin Peanut failed to
provide the FDA with sufficient data on manufacturing procedures and quality controls; (2) consequently, DBV Technologies
voluntarily withdrew the BLA for Viaskin Peanut; and (3) as a result, defendants' statements about DBV Technologies' business,
operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the DBV Technologies S.A. class action contact jlevi@levikorsinsky.com.
Uxin Limited (NASDAQGS: UXIN)
Class Period: Pursuant and/or traceable to the Company’s Registration Statement and Prospectus issued in connection with
the June 27, 2018 initial public offering
Lead Plaintiff Deadline: April 12, 2019
Join the action: https://www.zlk.com/pslra-1/uxin-limited-loss-form?wire=3
The Registration Statement was materially false and misleading and omitted to state that: (1) Uxin was likely to stop providing
complementary services such as inspections to its customers; (2) instead, Uxin would connect consumers to dealers who would provide
such complementary services; (3) as a result, Uxin’s 2B business would be materially impacted; and (4) consequently, Defendants’
statements in the Registration Statement regarding Uxin’s business, operations, and prospects, were materially false and/or
misleading.
To learn more about the Uxin Limited class action contact jlevi@levikorsinsky.com.
Maiden Holdings, Ltd. (NASDAQGS: MHLD)
Class Period: March 4, 2014 - November 9, 2018
Lead Plaintiff Deadline: April 12, 2019
Join the action: https://www.zlk.com/pslra-1/maiden-holdings-ltd-loss-form?wire=3
The complaint alleges that during the Class Period, defendants misrepresented the quality and nature of Maiden’s underwriting
and risk management policies and practices and the risks of its reinsurance portfolio. In particular, defendants misleadingly
claimed that they were subjecting AmTrust’s insurance portfolio to robust analysis and cross-checks to ensure that the Company had
appropriately priced the risk of reinsuring AmTrust’s insurance portfolio. In truth, the Company had failed to employ sufficient
underwriting and risk management protocols and had largely abdicated its responsibility to ensure that its AmTrust Reinsurance
segment priced policies commensurate with the risk assumed by the Company.
To learn more about the Maiden Holdings, Ltd. class action contact jlevi@levikorsinsky.com.
Bridgepoint Education Inc. (NYSE: BPI)
Class Period: March 8, 2016 - March 7, 2019
Lead Plaintiff Deadline: May 10, 2019
Join the action: https://www.zlk.com/pslra-1/bridgepoint-education-inc-loss-form?wire=3
About the lawsuit: During the class period, Bridgepoint Education Inc. allegedly made materially false and/or misleading
statements and/or failed to disclose that: (i) Bridgepoint’s processes for recording revenue for its FTG program were inaccurate;
(ii) Bridgepoint maintained deficient internal controls; (iii) due to the foregoing deficiencies, Bridgepoint was prone to and did
commit material accounting errors related to revenue, provision for bad debts, accounts receivable and deferred revenue, which
resulted in the overstatement of revenue and expenses; and (iv) as a result, Bridgepoint’s public statements were materially false
and misleading at all relevant times.
To learn more about the Bridgepoint Education Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
